This article was recently shared with me, but it doesn’t say too much:
I think the most telling line is this:
Our goal is to find a small molecule that improves the function of the mutant protein, helping it behave more like the wild-type. Ultimately, we’re aiming to restore near-normal function in the mutant.
What do we know about the potential of this approach, and the potential time this might take? I know you guys are aware of the research to some degree, as it looks like you had an interview with Arne back in 2022.
I guess I’m just wondering if there’s much progress and potential here.